We’re Here to Restore What Was Lost.
We believe the body holds the key to healing. Our mission is to redefine what’s possible for patients with Short Bowel Syndrome through breakthrough regenerative technology.
Built to Regrow the Intestine. Built to Give Hope.
We are a medical device company on a mission to change how we treat intestinal failure. Inspired by the resilience of the human body and guided by years of surgical innovation and research, we’re developing the first regenerative therapy for patients with Short Bowel Syndrome (SBS).
We’re not just building a device, we’re building a future where children and adults can live longer, healthier lives without relying on parenteral nutrition or facing the risks of transplantation.
Our Vision
A World Where Regeneration Replaces Replacement.
Our vision is bold: a world where intestinal regeneration becomes the new standard of care for SBS. We imagine a future where the body’s own tissue can be gently guided to rebuild, restoring health from within. We’re working to make that future a reality—starting with our lead investigational device, the Eclipse XL1.
Clinicians. Innovators. Changemakers.
We are a cross-disciplinary team of physicians, engineers, scientists, and operators, united by the belief that the best solutions come from collaboration and bold thinking. Every one of us is driven by the same goal: to restore health and dignity to those living with SBS.
Andre Bessette
CEO, Co-Founder
Vantage Surgical, SentreHeart, PEAK Surgical, ArthroCare
James Dunn, MD
PhD Co-Founder
Chief of Pediatric Surgery, Stanford University Former Chief of Pediatric Surgery, UCLA
Tom Krummel, MD
Co-Founder
Professor of Surgery, Stanford University Co-Director, Stanford Biodesign Program
Michael Helmrath, MD
Advisor
Pediatric Surgeon, Cincinnati Children’s Hospital Professor of Surgery, Cincinnati School of Medicine
Mark Puder, MD
Advisor
Professor of Surgery, Harvard Medical School Pediatric Surgeon, Boston Children’s Hospital
James Wall, MD
Advisor
Pediatric Surgeon, Stanford University Co-Director, Stanford Biodesign Program
Jon A. Vanderhoof, MD
Advisor
Attending, Division of Gastroenterology, Hepatology and Nutrition Senior Lecturer of Pediatrics, Harvard Medical School
Proudly Partnered
Our commitment to patient-centered innovation is driven by our partnerships with some of the leading healthcare organizations in the world. Eclipse Regenesis is proudly partnered with Boston Children’s Hospital, Cincinnati Children’s, UCLA Health, and Stanford Medicine. Together with our partners, we continue to pioneer the next generation of treatment for patients with Short Bowel Syndrome (SBS).
Join Us on the Path to Healing
Whether you’re a patient, clinician, or partner, there’s a place for you in the Eclipse journey. Get in touch or follow our updates as we reshape what’s possible in intestinal care.